Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug targets Hard-to-Treat cancers in early trial

NCT ID NCT07356453

First seen Jan 28, 2026 · Last updated May 19, 2026 · Updated 12 times

Summary

This early-phase study tests a new drug called FORX-428 in people with advanced solid tumors that have certain gene changes (like BRCA1/2 mutations). The main goal is to find a safe dose and see how the drug affects the cancer. About 40 adults who have already tried standard treatments will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Knight Cancer Institute

    RECRUITING

    Portland, Oregon, 97239, United States

    Contact Phone: •••-•••-••••

  • NEXT - Virginia Cancer Specialists

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact Phone: •••-•••-••••

  • START - Midwest

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

    Contact Phone: •••-•••-••••

  • START - San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact Phone: •••-•••-••••

  • Stanford University Medical Center

    RECRUITING

    Palo Alto, California, 94304, United States

    Contact Phone: •••-•••-••••

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Phone: •••-•••-••••

  • University of Texas - MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-••••

  • Washington University St. Louis

    RECRUITING

    St Louis, Missouri, 63108, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.